Have multiple conditions? Click here

New Clinical Trials for Gastroesophageal Reflux Disease

While a lot is known about Gastroesophageal reflux disease there is still a lot this is not understood about the correlation between heartburn, the amount of damage to the esophagus and the number of bouts of Gastroesophageal reflux disease. For this reason there is a need for ongoing Gastroesophageal reflux disease clinical studies.
 
If you suffer from Gastroesophageal reflux disease perhaps you can help find relief for you and the millions of others who suffer from this uncomfortable ailment. There are ongoing Gastroesophageal reflux disease clinical trials that you can participate in at no cost to you. Simply review the list of current trials and contact us if you think you may qualify.
 

What is Gastroesophageal Reflux Disease?

Gastroesophageal reflux disease (GERD) is known by several names including gastro-oesophageal reflux disorder (GORD), gastric reflux disease, and acid reflux disease. It occurs when stomach acid repeatedly comes up into the esophagus and causes damage. A common symptom of Gastroesophageal reflux disease is heartburn. The symptoms may last just a short time or in many cases they become chronic. Some sufferers also vomit as a result of the Gastroesophageal reflux disease.
 

Gastroesophageal Reflux Disease Treatments

In many cases Gastroesophageal reflux disease can be prevented with diet and other lifestyle changes. Eating smaller, more frequent meals instead of larger meals is recommended. Not eating a few hours before bed has proven beneficial. Sleeping with the entire upper body slightly raised can also help. If these changes don’t help in treating Gastroesophageal reflux disease there are several drugs that may be prescribed. Proton pump inhibitors stop acid production where it originates from, thus alleviating the problem. Antacids and alginic acid are also often prescribed to treat Gastroesophageal reflux disease. In extreme cases surgery may be required.

Have multiple conditions? Click here

Showing 1-100 of 127
There are 127 Gastroesophageal Reflux Disease Clinical Trials
Name City State Zip
Gastroesophageal Reflux Disease Clinical Trial Birmingham AL 35216
Gastroesophageal Reflux Disease Clinical Trial Port Orange FL 32129
Gastroesophageal Reflux Disease Clinical Trial DeLand FL 32720
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Birmingham AL
Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD Tucson AZ 85723
Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. Tucson AZ 85723
The Effect of High PCO2 Solution on Esophageal Acid Sensation Tucson AZ 85723
Comparison of Nexium VS. Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. Tucson AZ 85723
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) Scottsdale AZ 85259
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Safford AZ 85546
Functional Dyspepsia Treatment Trial Phoenix AZ 85054
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Peoria AZ
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Mesa AZ 85201
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Little Rock AR
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Little Rock AR
Biology in Patients With Reflux Esophagitis Ventura CA 93003
Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus Stanford CA 94305
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Santa Clara CA 95051
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Santa Clara CA 95051
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Santa Clara CA 95051
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin Sacramento CA 95817
Montelukast in the Treatment of Duodenal Eosinophilia Los Angeles CA 20027
PPI Versus Placebo in Severe Functional Heartburn Los Angeles CA 90033
Pepsin As A Biomarker For Aspiration Los Angeles CA 90027
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain Los Angeles CA 90027
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) Anaheim CA 92801
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Englewood CO 80110
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Denver CO
Functional Dyspepsia Treatment Trial Darien CT 06820
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Washington
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Washington
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Ocala FL 34471
Functional Dyspepsia Treatment Trial Jacksonville FL 32224
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) Jacksonville FL 32224
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Celebration FL
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Celebration FL
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia Suwanee-Duluth GA 30096
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Atlanta GA 30342
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Atlanta GA 30342
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Atlanta GA 30308
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Atlanta GA
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Atlanta GA
Domperidone for Relief of Gastrointestinal Disorders Urbana IL 61801
Functional Dyspepsia Treatment Trial Chicago IL 60611
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study Chicago IL 60611
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Centralia IL
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Jeffersonville IN
Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) Indianapolis IN 46202
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Hobart IN 46342
Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy Iowa City IA 52242
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Salem KY 42078
Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants Louisville KY 40202
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Louisville KY
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Louisville KY
Correlation of High Resolution Esophageal Manometry With Symptoms Louisville KY 40202
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Metairie LA
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Metairie LA
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Baton Rouge LA 70808
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Chevy Chase MD 20815
Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children Baltimore MD 21205
Predicting Risk of Cancer in Barrett's Esophagus Baltimore MD 21205
Defining Central Circuits of Pain Charlestown MA 02129
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Boston MA
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Detroit MI
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Detroit MI
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study Detroit MI 48202
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Allegan MI 49010
Functional Dyspepsia Treatment Trial Rochester MN
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) Rochester MN 55905
[13C]-Spirulina Platensis GEBT Rochester MN
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Jackson MS
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Jackson MS
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive St Louis MO
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) St Louis MO
Functional Dyspepsia Treatment Trial Saint Louis MO 63130
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Omaha NE
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Omaha NE
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive West Orange NJ
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) West Orange NJ
Does Small Intestinal Bacterial Overgrowth Contribute to Functional Dyspepsia Albuquerque NM 87131
Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome New York NY 10019
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Albany NY
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Albany NY
Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux Winston-Salem NC 27157
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Charlotte NC
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease Chapel Hill NC 27599
Do Acid Sensing Ion Channels Contribute to Heartburn? Chapel Hill NC 27599
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn Chapel Hill NC 27599
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive Lima OH
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). Lima OH
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Lima OH
Gastric Accommodation and Gastroesophageal Reflux Columbus OH 43205
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study Columbus OH 43210
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) Oklahoma City OK 73112
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study Portland OR 97220
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study Portland OR 97239
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) Medford OR
The Effect of Nexium on Transmucosal Esophageal Leak Wynnewood PA 19096
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease Pittsburgh PA 15213
Esophageal Cancer Risk Registry Pittsburgh PA 15232

Showing 1-100 of 127
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register